These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19448679)

  • 41. Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
    Pratesi C; Simonelli C; Zanussi S; Talamini R; Bortolin MT; Tedeschi R; Marus A; Caffau C; Michieli M; Tirelli U; De Paoli P
    Clin Exp Immunol; 2008 Jan; 151(1):101-9. PubMed ID: 17931391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. BEAM-Campath Allogeneic Stem Cell Transplant for Patients with Relapsed/Refractory Lymphoma: High Incidence of Long-Term Mixed Donor-Recipient Chimerism and the Response to Donor Lymphocyte Infusions.
    Burney C; Wadhera K; Breslin P; Pearce R; Wells M; Alajangi R; Protheroe R; Marks DI; Griffin J; Robinson S
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2271-2278. PubMed ID: 32890747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-dose therapy for lymphoma.
    Shepherd JD; Phillips GL
    Curr Opin Oncol; 1993 Sep; 5(5):797-804. PubMed ID: 8105974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
    Wang H; Cui X; Shao Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hematopoietic stem cell transplantation for AIDS-related malignancies.
    Krishnan A; Forman SJ
    Curr Opin Oncol; 2010 Sep; 22(5):456-60. PubMed ID: 20639760
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.
    Scordo M; Bhatt V; Hsu M; Omuro AM; Matasar MJ; DeAngelis LM; Dahi PB; Moskowitz CH; Giralt SA; Sauter CS
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):38-43. PubMed ID: 27713090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.
    Davison K; Chen BE; Kukreti V; Couban S; Benger A; Berinstein NL; Kaizer L; Desjardins P; Mangel J; Zhu L; Djurfeldt MS; Hay AE; Shepherd LE; Crump M
    Ann Oncol; 2017 Mar; 28(3):622-627. PubMed ID: 27993811
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Autologous stem cell transplantation in HIV-positive patients affected by relapsed/partially responding lymphoma: let it be.
    Zanet E; Michieli M; Tirelli U
    Expert Rev Hematol; 2016 Jul; 9(7):617-9. PubMed ID: 27269371
    [No Abstract]   [Full Text] [Related]  

  • 49. Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant.
    Smith SM; van Besien K; Carreras J; Bashey A; Cairo MS; Freytes CO; Gale RP; Hale GA; Hayes-Lattin B; Holmberg LA; Keating A; Maziarz RT; McCarthy PL; Navarro WH; Pavlovsky S; Schouten HC; Seftel M; Wiernik PH; Vose JM; Lazarus HM; Hari P
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):904-12. PubMed ID: 18640574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
    Jost LM; Honegger HP; Stahel RA
    Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation combined with high dose radiotherapy and chemotherapy].
    Wang HQ; Cui XZ; Ren XB; Liu XM; Dai RZ; Zhang HL; Huang WY; Li W; Hao XS
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):948-51. PubMed ID: 12899794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-dose chemotherapy and autologous stem cell transplantation for multiple myeloma in HIV-positive patients in the highly active antiretroviral therapy era: the myeloma institute of research and therapy experience.
    Muzaffar J; Usmani S; Abdallah AO; Anaissie E; Cottler-Fox M; Restrepo A
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):171-4. PubMed ID: 23313066
    [No Abstract]   [Full Text] [Related]  

  • 53. High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma.
    Martin N; Borchiellini D; Coso D; Gastaud L; Boscagli A; Saudes L; Re D; Gutnecht J; Garnier G; Petit E; Barriere J; Naman H; Rossignol B; Thyss A; Peyrade F
    Leuk Lymphoma; 2015; 56(8):2379-87. PubMed ID: 25563428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The value of complete remission according to positron emission tomography prior to autologous stem cell transplantation in lymphoma: a population-based study showing improved outcome.
    Noring K; Carlsten M; Sonnevi K; Wahlin BE
    BMC Cancer; 2021 May; 21(1):500. PubMed ID: 33947353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infections in patients managed at home during autologous stem cell transplantation for lymphoma and multiple myeloma.
    Herrmann RP; Trent M; Cooney J; Cannell PK
    Bone Marrow Transplant; 1999 Dec; 24(11):1213-7. PubMed ID: 10642811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991.
    Bennett CL; Armitage JL; Armitage GO; Vose JM; Bierman PJ; Armitage JO; Anderson JR
    J Clin Oncol; 1995 Apr; 13(4):969-73. PubMed ID: 7707125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma.
    Stewart DA; Vose JM; Weisenburger DD; Anderson JR; Ruby EI; Bast MA; Bierman PJ; Kessinger A; Armitage JO
    Ann Oncol; 1995 Mar; 6(3):263-6. PubMed ID: 7612492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation.
    Molina A; Zaia J; Krishnan A
    Blood Rev; 2003 Dec; 17(4):249-58. PubMed ID: 14556780
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.
    Freytes CO; Loberiza FR; Rizzo JD; Bashey A; Bredeson CN; Cairo MS; Gale RP; Horowitz MM; Klumpp TR; Martino R; McCarthy PL; Molina A; Pavlovsky S; Pecora AL; Serna DS; Tsai T; Zhang MJ; Vose JM; Lazarus HM; van Besien K;
    Blood; 2004 Dec; 104(12):3797-803. PubMed ID: 15280203
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging.
    Kessinger A; Vose JM; Bierman PJ; Armitage JO
    Exp Hematol; 1991 Nov; 19(10):1013-6. PubMed ID: 1680733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.